Back to Archived Journals » Core Evidence » Volume 1-Issues 3 & 4 » Issue 4

Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Archive: Volume 1-Issues 3 & 4, 2006


Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia

Louise Profit

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

Ciclesonide in persistent asthma: the evidence of its therapeutic value

Charlotte A. Kenreigh, Linda Timm Wagner, Paul Chrisp

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

Aripiprazole: the evidence of its therapeutic impact in schizophrenia

William Winlow, Louise Profit, Paul Chrisp

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

Bortezomib: the evidence of its clinical impact in multiple myeloma

Simon Lancaster

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006